Latest News

Filters

Filter by tags: Iodine-131 Clear all tag filters

49 news articles found


Russia’s Kursk NPP has sent the first batch of cobalt-60 (Co-60) for shipment to the customer. The material was transported in specialised containers to a redistribution centre for delivery to the customer. The shipment is enough to sterilise at least 15,000 cubic metres of medical devices.

Date: Wednesday, 26 July 2023
Original article: neimagazine.com/news/newskursk-npp-delivers-first-batch-of-cobalt-60-isotope-11027702

International Atomic Energy Agency (IAEA) Director General Rafael Mariano Grossi says IAEA experts present at Ukraine’s Zaporizhia NPP (ZNPP) have in recent days and weeks inspected parts of the facility – including some sections of the perimeter of the large cooling pond – and have also conducted regular walkdowns across the site, so far without observing any visible indications of mines or explosives.

Date: Friday, 07 July 2023
Original article: neimagazine.com/news/newsattack-on-zaporizhia-npp-may-have-been-averted-10988247

Russian nuclear utility Rosenergoatom (Electric Power Division of Rosatom) is expanding the range of radioactive isotopes produced at NPPs. In the near future, the production of the radioactive isotope samarium-153 will be launched at the Leningrad NPP. Radiopharmaceuticals based on samarium-153 (Sm-153) are widely used in nuclear medicine to reduce pain in bone metastases to provide palliative care to cancer patients, as well as in traumatology for chronic diseases of the musculoskeletal system.

Date: Wednesday, 21 June 2023
Original article: neimagazine.com/news/newsleningrad-npp-to-expand-medical-radioisotope-production-10952159

Production of medical isotopes - iodine-131 (I-131) and molybdenum-99 (Mo-99) is to begin at Russia’s Smolensk and Kursk NPPs following discussions held at Leningrad NPP. Participants included representatives of nuclear utility Rosenergoatom, specialists from the Leningrad, Smolensk and Kursk plants and equipment developers from the NA Dollezhal Scientific Research & Design Institute of Power Engineering (Nikiet).

Date: Thursday, 15 June 2023
Original article: neimagazine.com/news/newsrosenergoatom-to-produce-medical-isotopes-at-two-more-npps-10941177

The Korea Atomic Energy Research Institute (KAERI) has said that first concrete has been poured for its Kijang Research Reactor (KJRR) at the Radiology Science Industrial Complex in Gijang-gun, Busan.

Date: Wednesday, 10 May 2023
Original article: neimagazine.com/news/newsfirst-concrete-for-koreas-new-research-reactor-10831766

The first concrete has been poured for the Kijang Research Reactor (KJRR) at the Radiology Science Industrial Complex in Gijang-gun, Busan, the Korea Atomic Energy Research Institute (KAERI) announced.

Date: Thursday, 04 May 2023
Original article: world-nuclear-news.org/Articles/Korea-starts-construction-of-new-research-reactor

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

The University of Missouri has launched an initiative to build a new, larger research reactor, NextGen MURR. The university's existing MU Research Reactor (MURR) - in operation for more than half a century - is the highest-powered university research reactor in the USA and is currently the country's only producer of certain medical radioisotopes.

Date: Saturday, 01 April 2023
Original article: world-nuclear-news.org/Articles/New-isotope-producing-research-reactor-for-Missour

Belgium’s Institute for Radioelements (IRE), a key producer of molybdenum-99 (Mo-99) and iodine-131 (I-131) widely used in nuclear medicine, has complete conversion of its production process to low-enriched uranium (LEU). This has ended the use of highly enriched uranium (HEU), which is seen as a proliferation risk.

Date: Friday, 31 March 2023
Original article: neimagazine.com/news/newsbelgiums-ire-moves-to-100-low-enriched-uranium-10719323